Nicotinic Acetylcholine receptors Flashcards

1
Q

neuronal nAChR contain how many subunits?

A

5 subunits that are alpha, beta or all alpha

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how many types of alpha and beta subunits do neurons express?

A

neurons express at least nine alpha subunits (alpha2-alpha10) and three beta subunits (beta2-beta4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what properties does the association between different alpha and beta subunits confer?

A

a mutiltude of nAChRs that differ in their ion-gating and ligand-binding properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what type of nAChR subunit do human bronchial epithelial cells express and what is function?

A

human bronchial epithelial cells express functional nAChR of the alpha3 subtype which modulate cell shape and affect cell-cell contact (supports concept that nAChR modulate cellular functions other than synaptic transmission)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

acetylcholinesterase catalyzes the formation of…

A

ACh–>Choline and Acetate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Choline can activate

A

alpha 7 nAChR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

alpha7 nAChR characteristics

A

more permeable to calcium, desensitize quickly (only permit few ions to travel), are expressed in human bronchial epithelial cells, aortic endothelials cells and human skin keratinocytes
and can be activated by choline (degradation product of ACh)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is alpha-bungarotoxin

A

a-BTX is a competitive, relatively irreversible inhibitor of of muscle and alpha-7 nAChR subtypes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What enzyme is responsible for ACh synthesis?

A

Choline Acetyltransferase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the effects of ACh on the airways (receptor, effector cell, disease)

A

ACh activates the muscarinic AChR on airway smooth muscl and mucus producing cells to cause bronchoconstriction and mucus secretion in asthma and COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are emerging effects of ACh on airways?

A

inflammation, proliferation, fibrosis, airway remodeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Acetycholine is released from what type of cell?

A

ACh is released by parasympathetic nerves as a neurotransmitter and by epithelial and inflammatory cells as a paracrine or autocrine hormone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

bronchoconstriction and mucus secretion are regulated by what signaling mechanism?

A

parasympathetic NS is responsible for muscarinic control of bronchoconstriction and mucus secretion via
ACh signlaing to –>Gq coupled M1, M3 receptors
and ———————>Gi couples M2 receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Where are M1 receptors located?

A

at the ganglion in the postganglionic nerve, is common in exocrine glands and in the CNS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Where are M2 receptors located?

A

prejunctional (are autoinhibitory bc recall they are Gi coupled)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

function of M1 and M3 receptors?

A

involved in mucus, electrolyte and water secretion by submucosal glands

17
Q

function of M3 receptors

A

mediate bronchoconstriction on airway smooth muscle

18
Q

How is obstructive vs restrictive airway disease distinguished?

A

Obstructive lung diseases include conditions that make it hard to exhale all the air in the lungs (COPD, asthma, CF). People with restrictive lung disease have difficulty fully expanding their lungs with air (interstitial lung disease, ALS-neuromuscular disease)

19
Q

anticholinergic therapy mechanism

A

inhibits muscarinic M3 receptor: ipratropium, oxitropium (shortacting) and tioptropium (long acting)

20
Q

mainstay treatment for COPD

A

anticholinergic

21
Q

mainstay treatment for asthma

A

short acting Beta-2 agonist and then anticholinergic (less effective)
However for uncontrolled acute asthma, beta 2 agonist +ipratoprium improves lung functions and decreases hospital admissions

22
Q

combo treatments for asthma

A

glycopyronium + indacaterol; tiotropium +olodaterol; umeclidinium + vilanterol

once daily muscarinic antagonist + B2 agonist

goal: to simplify drug regimen and improved lung function over 24 h period